Sun Pharma Q2 profit plunges 36% on exceptional charges despite revenue growth
The Hindu · 30 October 2026
Excluding the exceptional items, adjusted net profit stood at ₹3,162 crore.
Full story published by The Hindu. Namaste Indian aggregates India headlines so you can discover and discuss them with people across every state.
Related articles
- India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
The Hindu
- China's GJ-21 stealth attack drone makes maiden takeoff and landing aboard amphibious assault ship
Firstpost
- India made ‘remarkable progress’ in reducing poverty: World Bank
The Hindu
- IREDA Appoints Jatin Kumar Nayak As CMD; To Head Renewable Energy Lender Until 2029
NDTV Profit
- IRDAI upgrades business analytics platform for health covers
The Hindu
- IRDAI declares Nov grievance resolution month
The Hindu